Your browser doesn't support javascript.
loading
Differential expression of MUC4, GPR110 and IL2RA defines two groups of CRLF2-rearranged acute lymphoblastic leukemia patients with distinct secondary lesions.
Sadras, Teresa; Heatley, Susan L; Kok, Chung H; Dang, Phuong; Galbraith, Kate M; McClure, Barbara J; Muskovic, Walter; Venn, Nicola C; Moore, Sarah; Osborn, Michael; Revesz, Tamas; Moore, Andrew S; Hughes, Timothy P; Yeung, David; Sutton, Rosemary; White, Deborah L.
Afiliação
  • Sadras T; Cancer Theme, South Australian Health & Medical Research Institute, Adelaide, SA, Australia; Discipline of Medicine, University of Adelaide, Adelaide, SA, Australia.
  • Heatley SL; Cancer Theme, South Australian Health & Medical Research Institute, Adelaide, SA, Australia; Discipline of Medicine, University of Adelaide, Adelaide, SA, Australia.
  • Kok CH; Cancer Theme, South Australian Health & Medical Research Institute, Adelaide, SA, Australia; Discipline of Medicine, University of Adelaide, Adelaide, SA, Australia.
  • Dang P; Cancer Theme, South Australian Health & Medical Research Institute, Adelaide, SA, Australia.
  • Galbraith KM; Cancer Theme, South Australian Health & Medical Research Institute, Adelaide, SA, Australia.
  • McClure BJ; Cancer Theme, South Australian Health & Medical Research Institute, Adelaide, SA, Australia.
  • Muskovic W; Molecular Diagnostics Program, Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, NSW, Australia.
  • Venn NC; Molecular Diagnostics Program, Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, NSW, Australia.
  • Moore S; Department of Genetic Pathology, SA Pathology, Adelaide, SA, Australia.
  • Osborn M; SA Pathology at Women's & Children's Hospital, Adelaide, SA, Australia; Australian Genomic Health Alliance, Adelaide, SA, Australia.
  • Revesz T; SA Pathology at Women's & Children's Hospital, Adelaide, SA, Australia.
  • Moore AS; The University of Queensland Diamantina Institute, UQ Child Health Research Centre, The University of Queensland, Brisbane, QLD, Australia; Oncology Services Group, Children's Health Queensland Hospital and Health Service, Brisbane, QLD, Australia.
  • Hughes TP; Cancer Theme, South Australian Health & Medical Research Institute, Adelaide, SA, Australia; Discipline of Medicine, University of Adelaide, Adelaide, SA, Australia; Department of Haematology, SA Pathology, Adelaide, SA, Australia.
  • Yeung D; Department of Haematology, SA Pathology, Adelaide, SA, Australia.
  • Sutton R; Molecular Diagnostics Program, Children's Cancer Institute, Lowy Cancer Research Centre, UNSW Sydney, NSW, Australia; Australian Genomic Health Alliance, Adelaide, SA, Australia; School of Women's and Children's Health, Medicine, University of NSW, Sydney, NSW, Australia.
  • White DL; Cancer Theme, South Australian Health & Medical Research Institute, Adelaide, SA, Australia; Discipline of Medicine, University of Adelaide, Adelaide, SA, Australia; Australian Genomic Health Alliance, Adelaide, SA, Australia. Electronic address: deborah.white@sahmri.com.
Cancer Lett ; 408: 92-101, 2017 11 01.
Article em En | MEDLINE | ID: mdl-28866095
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rearranjo Gênico / Regulação Leucêmica da Expressão Gênica / Proteínas Oncogênicas / Receptores de Citocinas / Receptores Acoplados a Proteínas G / Subunidade alfa de Receptor de Interleucina-2 / Leucemia-Linfoma Linfoblástico de Células Precursoras / Mucina-4 Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Cancer Lett Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Austrália
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Rearranjo Gênico / Regulação Leucêmica da Expressão Gênica / Proteínas Oncogênicas / Receptores de Citocinas / Receptores Acoplados a Proteínas G / Subunidade alfa de Receptor de Interleucina-2 / Leucemia-Linfoma Linfoblástico de Células Precursoras / Mucina-4 Tipo de estudo: Prognostic_studies Limite: Female / Humans Idioma: En Revista: Cancer Lett Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Austrália